KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Canopy Growth (CGC) EBT (2017 - 2025)

Historic EBT for Canopy Growth (CGC) over the last 9 years, with Q4 2025 value amounting to -$44.7 million.

  • Canopy Growth's EBT rose 4869.24% to -$44.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$495.3 million, marking a year-over-year decrease of 4377.29%. This contributed to the annual value of -$681.8 million for FY2025, which is 9490.12% down from last year.
  • Canopy Growth's EBT amounted to -$44.7 million in Q4 2025, which was up 4869.24% from -$1.0 million recorded in Q3 2025.
  • Over the past 5 years, Canopy Growth's EBT peaked at $319.6 million during Q2 2021, and registered a low of -$1.6 billion during Q2 2022.
  • For the 5-year period, Canopy Growth's EBT averaged around -$210.0 million, with its median value being -$94.0 million (2021).
  • As far as peak fluctuations go, Canopy Growth's EBT soared by 43735.19% in 2021, and later plummeted by 131267.27% in 2024.
  • Over the past 5 years, Canopy Growth's EBT (Quarter) stood at -$91.8 million in 2021, then tumbled by 83.17% to -$168.1 million in 2022, then dropped by 1.09% to -$169.9 million in 2023, then skyrocketed by 48.79% to -$87.0 million in 2024, then surged by 48.69% to -$44.7 million in 2025.
  • Its EBT stands at -$44.7 million for Q4 2025, versus -$1.0 million for Q3 2025 and -$29.8 million for Q2 2025.